{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:06:53Z","timestamp":1791490013110,"version":"4.3.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Cancer Research, Pediatric Oncology Branch"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Neurofibromatosis type 1 (NF1) is a genetic cancer predisposition syndrome that can impact multiple organ systems and is associated with plexiform neurofibroma tumors, requiring care from birth through adulthood. Adolescents and young adults (AYAs) with NF1 face several barriers to transition from pediatric to adult care. This cross-sectional study aimed to assess transition readiness in this population and to evaluate relationships between specific NF1 symptoms and transition readiness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>AYAs (aged 16\u201324) enrolled in existing studies related to NF1 were eligible. AYAs and their parents completed measures of transition readiness (Transition Readiness Assessment Questionnaire version 4 [TRAQ-4]), and AYAs also completed a transition readiness interview (UNC TRxANSITION).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirty-eight AYAs (mean age\u2009=\u200919.95\u2009\u00b1\u20092.68\u2009years) participated in the study. Average TRAQ scores indicated that AYAs were still learning Self-Management skills (M\u2009=\u20093.37, SD\u2009=\u20091.08) and Self-Advocacy skills (M\u2009=\u20093.98, SD\u2009=\u20090.67). Older AYAs had higher TRAQ scores for Self-Management (r\u2009=\u20090.70, p &amp;lt; .001) and Self-Advocacy (r\u2009=\u20090.41, p = .011) than younger AYAs. Parents and AYAs had similar TRAQ scores. About one third of AYAs (37.8%, n\u2009=\u200914) expressed uncertainty about how NF1 might affect them in the future. The remaining AYAs mostly expressed concerns regarding tumor growth, pain, or cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this small study, preliminary findings suggest that AYAs with NF1 express confidence in many areas of transition readiness but continue to require support, particularly with Self-Management skills. Given the gaps in understanding of future health risks, AYAs with NF1 would benefit from early assessment, psychoeducation, and support for transition readiness to adult care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpepsy\/jsae006","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T06:16:20Z","timestamp":1708150580000},"page":"383-391","source":"Crossref","is-referenced-by-count":7,"title":["Perceived transition readiness among adolescents and young adults with neurofibromatosis type 1 and plexiform neurofibromas: a cross-sectional descriptive study"],"prefix":"10.1093","volume":"49","author":[{"given":"Atara","family":"Siegel","sequence":"first","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Lockridge","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari L","family":"Struemph","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Toledo-Tamula","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Little","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L","family":"Wolters","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dufek","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Tibery","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Baker","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte C","family":"Wideman","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci","family":"Martin","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"5","key":"2024061321012597500_jsae006-B1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"issue":"11","key":"2024061321012597500_jsae006-B2","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2337\/dc18-0351","article-title":"Executive function predicting longitudinal change in type 1 diabetes management during the transition to emerging adulthood","volume":"41","author":"Berg","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"2024061321012597500_jsae006-B3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11065-018-9380-x","article-title":"Social function and autism spectrum disorder in children and adults with neurofibromatosis type 1: A systematic review and meta-analysis","volume":"28","author":"Chisholm","year":"2018","journal-title":"Neuropsychology Review"},{"issue":"5","key":"2024061321012597500_jsae006-B4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cge.12551","article-title":"Depression among adults with neurofibromatosis type 1: Prevalence and impact on quality of life","volume":"88","author":"Cohen","year":"2015","journal-title":"Clinical Genetics"},{"issue":"1","key":"2024061321012597500_jsae006-B5","doi-asserted-by":"crossref","first-page":"i85","DOI":"10.1093\/noajnl\/vdz040","article-title":"Brain tumors in neurofibromatosis type 1","volume":"2","author":"Costa","year":"2020","journal-title":"Neuro-Oncology Advances"},{"issue":"7","key":"2024061321012597500_jsae006-B6","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/ajmg.a.61627","article-title":"Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: A nationwide study","volume":"182","author":"Doser","year":"2020","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"5","key":"2024061321012597500_jsae006-B7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1192\/bjp.2019.131","article-title":"Transition between child and adult services for young people with attention-deficit hyperactivity disorder (ADHD): Findings from a British national surveillance study","volume":"217","author":"Eke","year":"2020","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"issue":"1","key":"2024061321012597500_jsae006-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-017-0607-y","article-title":"Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire","volume":"15","author":"Ferner","year":"2017","journal-title":"Health and Quality of Life Outcomes"},{"issue":"6","key":"2024061321012597500_jsae006-B9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3109\/0886022X.2012.678171","article-title":"A clinical tool to measure the components of health-care transition from pediatric care to adult care: The UNC TRxANSITION Scale","volume":"34","author":"Ferris","year":"2012","journal-title":"Renal Failure"},{"issue":"1","key":"2024061321012597500_jsae006-B10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jpepsy\/jsr049","article-title":"Getting ready to leave: Transition readiness in adolescent kidney transplant recipients","volume":"37","author":"Gilleland","year":"2012","journal-title":"Journal of Pediatric Psychology"},{"issue":"3","key":"2024061321012597500_jsae006-B11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/24694193.2020.1806402","article-title":"Transition readiness assessment in adolescents and young adults with Neurofibromatosis type 1 (NF1)","volume":"46","author":"Goetsch-Weisman","year":"2020","journal-title":"Comprehensive Child and Adolescent Nursing"},{"issue":"7","key":"2024061321012597500_jsae006-B12","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/MIB.0000000000000419","article-title":"Concerns, barriers, and recommendations to improve transition from pediatric to adult IBD care: Perspectives of patients, parents, and health professionals","volume":"21","author":"Gray","year":"2015","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"2024061321012597500_jsae006-B13","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nature Reviews. Disease Primers"},{"issue":"12","key":"2024061321012597500_jsae006-B14","first-page":"973","article-title":"Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder","volume":"48","author":"Hyman","year":"2006","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"2","key":"2024061321012597500_jsae006-B15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00431-013-2128-y","article-title":"Depression and adherence to treatment in diabetic children and adolescents: A systematic review and meta-analysis of observational studies","volume":"173","author":"Kongkaew","year":"2014","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"2024061321012597500_jsae006-B16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ajmg.a.35840","article-title":"Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge","volume":"161A","author":"Oates","year":"2013","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"6","key":"2024061321012597500_jsae006-B17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"American Journal of Clinical Oncology"},{"issue":"8","key":"2024061321012597500_jsae006-B18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: An international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genetics in Medicine"},{"issue":"2","key":"2024061321012597500_jsae006-B19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/dmcn.13928","article-title":"Attention to faces in social context in children with neurofibromatosis type 1","volume":"61","author":"Lewis","year":"2019","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"3","key":"2024061321012597500_jsae006-B20","doi-asserted-by":"crossref","first-page":"e201965-e201965","DOI":"10.1001\/jamanetworkopen.2020.1965","article-title":"Small data challenges of studying rare diseases","volume":"3","author":"Mitani","year":"2020","journal-title":"JAMA Network Open"},{"key":"2024061321012597500_jsae006-B21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pedn.2017.08.033","article-title":"A parental report of youth transition readiness: The parent STARx questionnaire (STARx-P) and re- evaluation of the STARx child report","volume":"38","author":"Nazareth","year":"2018","journal-title":"Journal of Pediatric Nursing"},{"key":"2024061321012597500_jsae006-B22","author":"NF Collective","year":"2023"},{"issue":"8","key":"2024061321012597500_jsae006-B23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/1087054719894384","article-title":"Cognition, ADHD symptoms, and functional impairment in children and adolescents with neurofibromatosis type 1","volume":"25","author":"Payne","year":"2021","journal-title":"Journal of Attention Disorders"},{"issue":"3","key":"2024061321012597500_jsae006-B24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"The Journal of Pediatrics"},{"issue":"6","key":"2024061321012597500_jsae006-B25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0272989X08327068","article-title":"Decision making in the transtheoretical model of behavior change","volume":"28","author":"Prochaska","year":"2008","journal-title":"Medical Decision Making: An International Journal of the Society for Medical Decision Making"},{"key":"2024061321012597500_jsae006-B26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/PHMT.S362679","article-title":"Neurofibromatosis Type 1 (NF1): addressing the Transition from Pediatric to Adult Care. Pediatric.","volume":"14","author":"Radtke","year":"2023","journal-title":"Pediatric Health, Medicine and Therapeutics"},{"issue":"5","key":"2024061321012597500_jsae006-B27","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/ajmg.a.38680","article-title":"Worries and needs of adults and parents of adults with neurofibromatosis type 1","volume":"176","author":"Rietman","year":"2018","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"1","key":"2024061321012597500_jsae006-B28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/hematology.2019000054","article-title":"A program of transition to adult care for sickle cell disease","volume":"2019","author":"Saulsberry","year":"2019","journal-title":"Hematology. American Society of Hematology. Education Program"},{"issue":"2","key":"2024061321012597500_jsae006-B29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jpepsy\/jsp128","article-title":"Measuring the transition readiness of youth with special healthcare needs: Validation of the TRAQ\u2014Transition Readiness Assessment Questionnaire","volume":"36","author":"Sawicki","year":"2011","journal-title":"Journal of Pediatric Psychology"},{"issue":"10","key":"2024061321012597500_jsae006-B30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamapediatrics.2013.2223","article-title":"Stakeholder validation of a model of readiness for transition to adult care","volume":"167","author":"Schwartz","year":"2013","journal-title":"JAMA Pediatrics"},{"issue":"4","key":"2024061321012597500_jsae006-B31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/dme.12639","article-title":"The experiences and impact of transition from child to adult healthcare services for young people with type 1 diabetes: A systematic review","volume":"32","author":"Sheehan","year":"2015","journal-title":"Diabetic Medicine: a Journal of the British Diabetic Association"},{"issue":"9","key":"2024061321012597500_jsae006-B32","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/bjc.2015.78","article-title":"Age-specific risk of breast cancer in women with neurofibromatosis type 1","volume":"112","author":"Seminog","year":"2015","journal-title":"British Journal of Cancer"},{"issue":"3","key":"2024061321012597500_jsae006-B33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.14423\/SMJ.0000000000000950","article-title":"Lessons learned from building a pediatric-to-adult sickle cell transition program","volume":"112","author":"Smith","year":"2019","journal-title":"Southern Medical Journal"},{"issue":"7","key":"2024061321012597500_jsae006-B34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/gim.2018.28","article-title":"Care of adults with neurofibromatosis type 1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Stewart","year":"2018","journal-title":"Genetics in Medicine: official Journal of the American College of Medical Genetics"},{"issue":"2","key":"2024061321012597500_jsae006-B35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ajmg.a.62544","article-title":"Adolescents and young adults with neurofibromatosis type 1: a descriptive study of adaptive functioning","volume":"188","author":"Struemph","year":"2022","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"1","key":"2024061321012597500_jsae006-B36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.spen.2006.01.005","article-title":"Clinical manifestations and management of neurofibromatosis type 1","volume":"13","author":"Tonsgard","year":"2006","journal-title":"Seminars in Pediatric Neurology"},{"issue":"3","key":"2024061321012597500_jsae006-B37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1542\/peds.2009-2791","article-title":"Cystic fibrosis and transition to adult medical care","volume":"125","author":"Tuchman","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"2024061321012597500_jsae006-B38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1513\/AnnalsATS.201911-839OC","article-title":"Patterns of health insurance coverage and lung disease progression in adolescents and young adults with cystic fibrosis","volume":"18","author":"Tumin","year":"2021","journal-title":"Annals of the American Thoracic Society"},{"issue":"9","key":"2024061321012597500_jsae006-B39","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/ajmg.a.37123","article-title":"Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life","volume":"167A","author":"Wolters","year":"2015","journal-title":"American Journal of Medical Genetics. Part A"}],"container-title":["Journal of Pediatric Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpepsy\/article-pdf\/49\/6\/383\/58230250\/jsae006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpepsy\/article-pdf\/49\/6\/383\/58230250\/jsae006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:54:36Z","timestamp":1718366076000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpepsy\/article\/49\/6\/383\/7608867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,2,15]]},"published-print":{"date-parts":[[2024,6,13]]}},"URL":"https:\/\/doi.org\/10.1093\/jpepsy\/jsae006","relation":{},"ISSN":["0146-8693","1465-735X"],"issn-type":[{"value":"0146-8693","type":"print"},{"value":"1465-735X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,2,15]]}}}